Nektar Therapeutics (NKTR) PT Raised to $95 at Wedbush
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $59.38 +2.98%
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Join SI Premium – FREE
Wedbush analyst Martin Fan raised the price target on Nektar Therapeutics (NASDAQ: NKTR) to $95.00 (from $70.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Everpure (P) PT Raised to $140 at Raymond James
- DOE selects CenterPoint Energy for $50M grid upgrade grant
- 37 Capital makes Colombian property payment and retires C$424,637 in debt
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
